NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a biotechnology firm focusing on cancer immunotherapies and targeted drug conjugates, with a current market capitalization of $37 million, has provided a ...

Like so many problems facing health service delivery in New Zealand, the primary driver for the proposed changes is inadequate resourcing, writes Associate Professor Ben Beaglehole ...

The 4th RNA-Targeted Drug Discovery Summit is returning once again this December, to reunite the largest community of thought leaders and experts in biology, chemistry and RNA therapeutics to ...

Over the course of the two days, RCMP arrested more than 30 individuals. While there was a focus on detecting and ...

US President Donald Trump delayed the start of tariffs on neighbors Mexico and Canada for a month Monday -- but China ...

China on Tuesday imposed tariffs on some U.S. imports in a swift response to new U.S. duties on Chinese goods, raising the ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Michael Olson, 56, drugged and raped a teenage girl for months and targeted several other minors for depraved abuse, ...

A teenager was arrested during a targeted operation at Poulton railway station aimed at disrupting the flow of drugs into the ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...